Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1108526.RA7zaD1pVY0b6TzXQvtj8pqFSSaBJ36AODeACaZ7OlEYg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1108526.RA7zaD1pVY0b6TzXQvtj8pqFSSaBJ36AODeACaZ7OlEYg130_assertion type Assertion NP1108526.RA7zaD1pVY0b6TzXQvtj8pqFSSaBJ36AODeACaZ7OlEYg130_head.
- NP1108526.RA7zaD1pVY0b6TzXQvtj8pqFSSaBJ36AODeACaZ7OlEYg130_assertion description "[Our findings suggest that lymphotoxin-LTBR and CXCL11-CXCR3 signalling represent therapeutic targets in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108526.RA7zaD1pVY0b6TzXQvtj8pqFSSaBJ36AODeACaZ7OlEYg130_provenance.
- NP1108526.RA7zaD1pVY0b6TzXQvtj8pqFSSaBJ36AODeACaZ7OlEYg130_assertion evidence source_evidence_literature NP1108526.RA7zaD1pVY0b6TzXQvtj8pqFSSaBJ36AODeACaZ7OlEYg130_provenance.
- NP1108526.RA7zaD1pVY0b6TzXQvtj8pqFSSaBJ36AODeACaZ7OlEYg130_assertion SIO_000772 24014111 NP1108526.RA7zaD1pVY0b6TzXQvtj8pqFSSaBJ36AODeACaZ7OlEYg130_provenance.
- NP1108526.RA7zaD1pVY0b6TzXQvtj8pqFSSaBJ36AODeACaZ7OlEYg130_assertion wasDerivedFrom befree-2016 NP1108526.RA7zaD1pVY0b6TzXQvtj8pqFSSaBJ36AODeACaZ7OlEYg130_provenance.
- NP1108526.RA7zaD1pVY0b6TzXQvtj8pqFSSaBJ36AODeACaZ7OlEYg130_assertion wasGeneratedBy ECO_0000203 NP1108526.RA7zaD1pVY0b6TzXQvtj8pqFSSaBJ36AODeACaZ7OlEYg130_provenance.